Thyrocare Technologies (BOM:539871) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Operating Cash Flow per Share?

Thyrocare Technologies's operating cash flow per share for the three months ended in Mar. 2025 was ₹0.00. Thyrocare Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Thyrocare Technologies was 12.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Thyrocare Technologies's Operating Cash Flow per Share or its related term are showing as below:

BOM:539871' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -8.4 Med: 13.85 Max: 41.8
Current: 18.6

During the past 11 years, Thyrocare Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.80% per year. The lowest was -8.40% per year. And the median was 13.85% per year.

BOM:539871's 3-Year OCF Growth Rate is ranked better than
66.47% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: 3 vs BOM:539871: 18.60

Thyrocare Technologies Operating Cash Flow per Share Historical Data

The historical data trend for Thyrocare Technologies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Operating Cash Flow per Share Chart

Thyrocare Technologies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Operating Cash Flow per Share

Get a 7-Day Free Trial

21.67

21.41

24.39

31.79

35.71

Thyrocare Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Thyrocare Technologies's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Thyrocare Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Thyrocare Technologies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Thyrocare Technologies's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (A: Mar. 2025 )	=	Cash Flow from Operations (A: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2025 )
	=	1913.2	/	53.577
	=	35.71

Thyrocare Technologies's Operating Cash Flow per Share for the quarter that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	0	/	51.863
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Thyrocare Technologies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (BOM:539871) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

THYROCARE:India

Address

D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines